SLC5A2 and hepatocellular carcinoma: Conversely, in vitro studies have demonstrated that CA (100 μM) interferes with the anti-proliferative effects on non-small lung cancer cell, indicating that high doses of SGLT2 may inhibit HCC cell proliferation due to cytotoxicity [43].